市場調查報告書
商品編碼
1467690
2024-2032 年按設備類型、最終用戶和地區分類的周邊血管設備市場報告Peripheral Vascular Devices Market Report by Device Type, End User, and Region 2024-2032 |
2023年,全球IMARC Group血管器械市場規模達1,16億美元。
週邊血管疾病 (PVD) 是由於心臟和大腦外部血管狹窄、阻塞或痙攣而引起的循環系統疾病。這種情況會減少血管中的血流量,導致虛弱、疼痛、壞疽、腿部除毛、麻木和肌肉沉重。週邊血管裝置,如血管成形術導管、週邊導絲、腔靜脈過濾器、支架移植物和栓塞保護裝置 (EPD),用於治療動脈阻塞和狹窄。這些阻塞,尤其是在周邊脈管系統中發現的阻塞,是由斑塊堆積引起的,斑塊堆積限制了血管並減少了流向身體部位的血流。週邊血管裝置是安全的,可以最大限度地減少感染和刺激的風險,改善血流,並透過動脈供應含氧血液。
全球靜脈疾病或 CVI(慢性靜脈功能不全)的盛行率不斷上升,為市場創造了積極的前景。週邊血管裝置為大腦、腿部和足部提供充足的血流,以確保正常功能。此外,老年人口的增加以及週邊動脈疾病(PAD)和阻塞等各種疾病發病率的增加也有利於市場的成長。此外,這可以歸因於生活習慣的改變,包括吸煙和大量飲酒,再加上缺乏身體活動和不健康的飲食習慣。除此之外,由於併發症更少、術後疼痛更少、住院時間更短和恢復時間更快,人們越來越傾向於微創手術(MIS),這也推動了市場的成長。此外,由於動脈粥狀硬化、肥胖和生活方式相關疾病的日益流行,斑塊切除裝置的廣泛採用正在對市場成長產生積極影響。其他因素,包括醫療保健行業的顯著成長、消費者支出能力的提高以及廣泛的研發 (R&D) 活動,預計將推動市場成長。
The global peripheral vascular devices market size reached US$ 11.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.
Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.
The increasing prevalence of venous diseases or CVI (chronic venous insufficiency) across the globe is creating a positive outlook for the market. Peripheral vascular devices provide sufficient blood flow to the brain, legs, and feet for proper functioning. Additionally, the rising geriatric population and the increasing incidences of various ailments, such as peripheral artery disease (PAD) and blockages, are favoring the market growth. Furthermore, this can be attributed to changing lifestyle habits, including smoking and high alcohol consumption, coupled with physical inactivity and unhealthy dietary habits. Apart from this, the growing inclination toward minimally invasive surgeries (MIS) due to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times are providing an impetus to the market growth. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral vascular devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type and end user.
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
Peripheral Transluminal Angioplasty (PTA) Guidewires
Atherectomy Devices
Embolic Protection Devices
Inferior Vena Cava Filters
Others
Hospitals and Clinics
Ambulatory Care Centers
Specialty Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.